期刊文献+

胃癌患者血清内皮抑素和VEGF水平与其临床病理特征的关系研究

下载PDF
导出
作者 丁红辉
出处 《浙江临床医学》 2008年第3期375-376,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献10

  • 1O'ReillyMS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88 (2) :277 - 285.
  • 2Feldman AL, Alexander HR J r, Bartlett DL, et al. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann Surg Oncol,2001,8(9) :741 - 745.
  • 3Standker L , Schrader M , Kanse SM , et al. Isolation and characterization of the circulating form of human Endostatin. FEBS Lett, 1997,42 : 129.
  • 4Poon RT, Fan ST, Wong J. Clinical imp lications of circulating angiogenic factors in cancer patients. J Clin Oncol, 2001, 19(4) : 1207 - 1225.
  • 5Kuroi K, Tanaka C, Toi M. Circulating levels of Endostatin in cancer patients. Oncol Rep, 2001, 8 (2) : 405.
  • 6Feldman AL, Pak H, Yang JC, et al. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer ,2001 ,91 (8) : 1525 - 1529.
  • 7Marti HH, RisauW. Systemic hypoxia ehanges the organ- specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA, 1998, 95(26) : 15809 -15814.
  • 8Wen W, Moses MA, Wiederschain D, et al, The generation of en2dostatin ismediated by elastase. Cancer Res, 1999,59(24):6052- 6056.
  • 9Mauem J , Stammler G, Koomagi R , et al. Association of vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with clinicopathology and patients survival , and analysis of serum VEGF levels. Br J Cancer ,1997 ,76:1221.
  • 10刘福国,高艳景,王敏,许建民,陈建,赵幼安.血清VEGF和Endostatin水平与消化系肿瘤临床病理特征的关系[J].中国肿瘤生物治疗杂志,2006,13(4):290-295. 被引量:4

二级参考文献12

  • 1Kim YM,Hwang S,Kim YM,et al.Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1[J].J Biol Chem,2002,277 (31):27872-27879.
  • 2Feldman AL,Alexander HR Jr,Bartlett DL,et al.A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases[J].Ann Surg Oncol,2001,8(9):741-745.
  • 3Marti HH,Risau W.Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors[J].Proc Natl Acad Sci USA,1998,95(26):15809-15814.
  • 4Wen W,Moses MA,Wiederschain D,et al.The generation of endostatin is mediated by elastase[J].Cancer Res,1999,59 (24):6052-6056.
  • 5Folkman J.Role of angiogenesis in tumor growth and metastasis[J].Semin Oncol,2002,29(6 Suppl 16):15-18.
  • 6Brooks PC,Montgomery AM,Cheresh DA.Use of the 10-day-old chick embryo model for studying angiogenesis[J].Methods Mol Biol,1999,129:257-269.
  • 7O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:An endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
  • 8Folkman J,Watson K,Ingber D,et al.Induction of angiogenesis during the transition from hyperplasia to neoplasia[J].Nature,1998,339(6219):58-61.
  • 9Hanahan D,Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J].Cell,1996,86 (3):353-364.
  • 10Poon RT,Fan ST,Wong J.Clinical implications of circulating angiogenic factors in cancer patients[J].J Clin Oncol,2001,19(4):1207-1225.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部